Novartis | Marknadsvärde



Market Capitalization Ändra Datum
AbbVie USD 350.71B 19.93B 2025-05
Amgen USD 150.93B 16.57B 2025-05
AstraZeneca GBP 166.72B 7.79B 2025-05
Bausch Health Companies CAD 2.71B 740.13M 2025-05
Biogen USD 17.88B 2.15B 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Canopy Growth CAD 612.33M 169.68M 2024-12
Corcept Therapeutics USD 5.28B 444M 2024-12
Eli Lilly USD 782.87B 41.21B 2025-05
Gilead Sciences USD 129.47B 10.21B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Indivior 904.38M 0 2025-05
J&J USD 374.87B 24.78B 2025-05
Merck USD 212.34B 13.54B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pacira USD 870M 176M 2024-12
Perrigo USD 3.51B 70M 2024-12
Pfizer USD 137.09B 6.62B 2025-05
Prestige Brands USD 3.86B 285M 2024-12
Sanofi EUR 122.48B 3.37B 2025-05
Supernus Pharmaceuticals USD 2.02B 294M 2024-12



Novartis Marknadsvärde - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.